CEO to Present at Global Onemed Forum
Melbourne, Jan 13, 2015 AEST (ABN Newswire) - Melbourne technology firm, Rhinomed (
ASX:RNO) today announced that CEO and Managing Director Mr. Michael Johnson will present a company update at the 8th Annual OneMed Forum on Monday, 12th January 2015 at 11.40 PST at the Marriott Marquis in San Francisco.
The two-day OneMed event that begins today (US time) coincides with the 33rd Annual JP Morgan Healthcare Conference. The JP Morgan conference has now created a week of events in San Francisco which provides an opportunity for briefings from emerging companies, large pharmaceutical companies, public and private investors, analysts, bankers, industry professionals and US institutional investors.
Mr. Johnson will provide an update on the company's progress and plans for 2015. A presentation will be given at the Marriot Marquis at 11.40 (PST) today.
A copy of the presentation can be found on the Rhinomed website. www.rhinomed.global Media Enquiries
About Rhinomed Limited
Rhinomed Limited (ASX:RNO) is a Melbourne based technology firm with a focus on nasal, respiratory and breathing management technologies. The company is seeking to monetise applications of its technology portfolio in the Sport, Sleep, Wellbeing and Drug Delivery markets. For more information, go to www.rhinomed.global
Follow the Turbine on Twitter at @theturbinecom
Follow Mute Snoring on Twitter at @mutesnoring
| ||
|
